What are the differences between nephrotic syndrome and nephritic syndrome, including their causes and diagnostic approaches?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differences Between Nephrotic and Nephritic Syndrome

Nephrotic syndrome and nephritic syndrome are distinct glomerular disorders with different clinical presentations, underlying causes, and management approaches.

Key Differences

Feature Nephrotic Syndrome Nephritic Syndrome
Definition Heavy proteinuria (>3.5g/24h), hypoalbuminemia (<3.0g/dL), edema, hyperlipidemia Hematuria, proteinuria (usually non-nephrotic), hypertension, abnormal kidney function
Pathophysiology Damage to podocytes and glomerular filtration barrier Inflammation of glomeruli
Clinical Presentation Peripheral edema, foamy urine, fatigue Hematuria (tea/cola-colored urine), hypertension, oliguria
Prognosis Variable depending on cause Generally poorer than nephrotic syndrome [1]

Causes of Nephrotic Syndrome

Primary Causes

  • Minimal change disease (most common in children)
  • Focal segmental glomerulosclerosis (FSGS)
  • Membranous nephropathy
  • Membranoproliferative glomerulonephritis

Secondary Causes

  • Diabetes mellitus
  • Systemic lupus erythematosus
  • Amyloidosis
  • HIV infection
  • Medications (NSAIDs, gold, penicillamine)
  • Malignancies

Causes of Nephritic Syndrome

Primary Causes

  • Post-infectious glomerulonephritis
  • IgA nephropathy (most common cause globally)
  • Rapidly progressive glomerulonephritis

Secondary Causes

  • Lupus nephritis
  • ANCA-associated vasculitis
  • Anti-glomerular basement membrane disease
  • Cryoglobulinemia
  • Henoch-Schönlein purpura

Diagnostic Approach

Nephrotic Syndrome

  1. Laboratory evaluation:

    • Urinalysis: Proteinuria, oval fat bodies, fatty casts
    • 24-hour urine protein: >3.5g/24h
    • Serum albumin: <3.0g/dL
    • Lipid profile: Elevated cholesterol and triglycerides
    • Renal function tests
  2. Additional testing:

    • Screen for secondary causes (diabetes, lupus, HIV)
    • Genetic testing in suspected hereditary forms 2
  3. Kidney biopsy:

    • Indicated in adults with nephrotic syndrome without clear etiology
    • May show diffuse foot process effacement in primary FSGS 3

Nephritic Syndrome

  1. Laboratory evaluation:

    • Urinalysis: Hematuria, red cell casts, proteinuria
    • Complement levels (often low in post-infectious GN, lupus nephritis)
    • ANCA, anti-GBM antibodies
    • Renal function tests
  2. Additional testing:

    • Streptococcal antibody titers (ASO, anti-DNase B)
    • ANA, anti-dsDNA for lupus
  3. Kidney biopsy:

    • Often necessary to determine specific cause and guide treatment

Management Approach

Nephrotic Syndrome

  1. Supportive care:

    • Edema management with diuretics
    • ACE inhibitors or ARBs for proteinuria
    • Statins for hyperlipidemia
    • Anticoagulation in high-risk patients (albumin <20g/L) 2
  2. Disease-specific therapy:

    • Primary FSGS: High-dose oral glucocorticoids (1mg/kg/day) for 4-16 weeks 3
    • Steroid-resistant cases: Consider calcineurin inhibitors 3
    • Genetic forms: Focus on supportive care rather than immunosuppression 2

Nephritic Syndrome

  1. Supportive care:

    • Blood pressure control
    • Management of acute kidney injury if present
  2. Disease-specific therapy:

    • Post-infectious GN: Antimicrobial therapy for underlying infection
    • IgA nephropathy: ACE inhibitors/ARBs, consider corticosteroids for persistent proteinuria
    • ANCA-associated vasculitis: Cyclophosphamide or rituximab plus corticosteroids 2
    • Lupus nephritis: Mycophenolate mofetil or cyclophosphamide plus glucocorticoids 2

Common Pitfalls to Avoid

  1. Treating genetic forms of nephrotic syndrome with immunosuppression
  2. Inadequate thromboprophylaxis in high-risk nephrotic patients
  3. Overreliance on serum albumin levels alone for fluid management
  4. Failure to monitor for infections in immunosuppressed patients
  5. Delaying genetic testing in suspected congenital/infantile cases 2

Monitoring

Regular monitoring should include:

  • Body weight and blood pressure
  • Renal function (eGFR, serum creatinine)
  • Proteinuria
  • Serum albumin
  • Urinary sediment
  • Growth velocity in pediatric patients 2

Response assessment should evaluate for complete response (return of serum creatinine to baseline and decline in proteinuria) or partial response (stabilization of serum creatinine but persistent proteinuria) 2.

References

Research

Nephritic Syndrome.

Primary care, 2020

Guideline

Nephritic and Nephrotic Syndrome Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.